Should We Use Ultrasound to Guide Transfemoral Access Routinely?

Currently, transfemoral access (TFA) is used in large-caliber procedures and when transradial access is not successful. The use of ultrasound (US) to guide access has emerged as a technique that allows for precise cannulation, avoiding accesses above and below the inguinal ligament. However, evidence regarding the effectiveness of this tool has shown variable results. Two surveys conducted among interventional cardiologists revealed that only 13%-27% of them use ultrasound, despite 88% of them reporting access to this technology in the cath laboratory.

The objective of this meta-analysis was to compare the use of ultrasound in guiding TFA with the lack of it.

The primary endpoint (PE) was defined as a combination of major vascular complications (including pseudoaneurysms, arteriovenous fistulas, retroperitoneal bleeding, hematomas with a diameter greater than 5 cm, limb ischemia requiring intervention or surgery) or major BARC 3 or 5 bleeding. The secondary endpoint (SE) consisted of a combination of major vascular complications, major or minor bleeding, and major vascular complications exclusively.

The analysis included 2441 patients, 1208 of whom were randomly assigned to the ultrasound-guided access group and 1233 to the group that did not use ultrasound. The average patient age was 65.5 years, and most subjects were men. Additionally, 12% of the patients had peripheral vascular disease, and 34% had undergone percutaneous coronary intervention with stent placement. Approximately 80% of the procedures were performed with 6-Fr catheters and, in half of the cases, operators used a percutaneous closure device.

Read also: Cardiac Angiography: Necessary for CABG Patient Diagnosis?

As for the results, there was a lower incidence of major vascular complications or major bleeding in the ultrasound-guided group compared with the group without ultrasound (2.8% vs. 4.5%; odds ratio [OR] 0.61, 95% confidence interval [CI]: 0.39-0.94; p=0.026). In the subgroup of patients who received closure devices, those assigned to the ultrasound-guided group experienced a reduction in major bleeding or major vascular complications (2.1% vs. 5.6%, OR 0.36, 95% CI: 0.19-0.69), while there were no significant benefits in the subgroup without closure devices (4.1% vs. 3.3%; OR 1.21, 95% CI: 0.65-2.26).

Conclusion

In summary, this meta-analysis demonstrates that the use of ultrasound to guide transfemoral access is associated with a lower risk of major bleeding and major vascular complications in coronary procedures. Furthermore, ultrasound guidance can be particularly beneficial in preventing vascular complications in patients receiving closure devices. Therefore, routine use of ultrasound for femoral access should be considered.

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data meta-analysis from the femoral ultrasound trialist collaboration.

Reference: Marc-André d’Entremont, MD, MPH et al EuroIntervention 2023;19-online publish-ahead-of-print October 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....